Beta Bionics Balance Sheet
NASDAQ: BBNXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Beta Bionics financial position
At the end of fiscal 2025, Beta Bionics reported total assets of $328.7 million, up 119.7% from a year earlier against total liabilities of $41.1 million. Shareholders' equity stood at $287.6 million, or 87.5% of assets. The company held $31.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 8.66, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Beta Bionics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Cash & Equivalents | 31.58M | 30.43M | 26.57M |
| Short-Term Investments | 187.55M | 73.14M | 70.18M |
| Receivables | 17.12M | 12.00M | 4.45M |
| Inventory | 21.72M | 13.32M | 1.25M |
| Total Current Assets | 267.90M | 132.92M | 103.62M |
| Property, Plant & Equipment | 8.60M | 4.78M | 2.48M |
| Long-Term Investments | 45.43M | — | — |
| Total Assets | 328.74M | 149.65M | 110.04M |
| Accounts Payable | 5.00M | 2.85M | 1.17M |
| Total Current Liabilities | 30.92M | 21.15M | 10.61M |
| Total Liabilities | 41.13M | 73.63M | 51.43M |
| Shareholders' Equity | 287.61M | -245.36M | -203.10M |
| Retained Earnings | -369.94M | -296.74M | -229.66M |
| Net Cash (Debt) | 219.13M | 103.58M | 96.75M |
| Shares Outstanding | 44.36M | 6.67M | — |
This table shows 3 annual periods of Beta Bionics's balance sheet, from FY 2025 back to FY 2023, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow BBNX's reporting calendar. What is a balance sheet?